Search
Displaying 291–300 of 585 for “Retinitis pigmentosa”
-
Endogena Launches Clinical Trial of Therapy to Activate Stem Cells in RP Patients’ Retinas
Research NewsThe emerging treatment is gene-agnostic.
-
Kiora to Launch Clinical Trial in Australia for Vision-Restoring Small Molecule for RP Patients
Research NewsThe approach bestows light sensitivity to retinal ganglion cells for people who have lost their photoreceptors
-
Research News
The newly approved drug reduces the pathologic hunger associated with BBS
-
AGTC’s XLRP Gene Therapy Performs Well in Extension of Phase 2 Clinical Trial
Research NewsThe three-month results support the planned launch of the company’s Phase 2/3 Vista trial
-
Cleanlogic Co-Founder’s Inspiration Comes From His Mom
Beacon StoriesIn honor of Mother’s Day, we’re sharing a special Beacon Story featuring Isaac Shapiro, co-founder of Cleanlogic. Isaac’s mother, Bea, lost her vision at only seven years old but went on to become an entrepreneur and help others in the blind and visually impaired community through adaptive technology.
-
Gene Knock-Out, Replacement Therapy for RP-RHO Performed Well in Lab Study
Research NewsEditas is planning IND-enabling studies of the two-part treatment in preparation for a clinical trial
-
Drug for Alcohol Abuse May Restore Vision for People with Retinal Diseases
Research NewsThe drug holds promise for enabling retinal-disease patients to get more vision from remaining photoreceptors
-
Aldeyra Launches Phase 2 Clinical Trial of Methotrexate Intravitreal Injections for RP
Research NewsLab studies showed the drug can effectively address the misfolded rhodopsin protein
-
Advocating for the Foundation Through Professional Outreach
Beacon StoriesAs a longtime supporter and advocate for the Foundation Fighting Blindness, Lora has recently begun working with the Professional Outreach team. Lora’s work helps eye care professionals in the Philadelphia region provide vital resources for their patients with inherited retinal diseases.
-
Second Sight Agrees to Merger to Maintain Retinal and Cortical Prostheses Programs
Research NewsCompany has been unable to meet revenue goals for the Argus II®
.png)
